Home › Teva Pharmaceutical Industries Given New $46.00 Price Target at BMO Capital Markets
 

Keywords :   


Teva Pharmaceutical Industries Given New $46.00 Price Target at BMO Capital Markets

2014-03-02 18:23:35| Biotech - Topix.net

BMO Capital Markets' price objective would indicate a potential downside of 7.80% from the company's current price.

Tags: price capital target industries

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news
»
13.10Atlantic Tropical Weather Outlook
13.10Eastern North Pacific Tropical Weather Outlook
13.10Port plan to go ahead after row over minister's comments
13.10Mortgage costs 'unlikely' to return to low levels
13.10How a Budget rule change could mean fewer tax rises
13.10Eastern North Pacific Tropical Weather Outlook
13.10Atlantic Tropical Weather Outlook
13.10Eastern North Pacific Tropical Weather Outlook
More »